Valuation: Bayer AG

Market Cap 43.19B 48.41B 40.24B 36.62B 68.95B 4,662B 69.46B 486B 189B 2,380B 182B 178B 7,649B P/E 2026 *
19.9x
P/E 2027 * 14.3x
Enterprise Value 73.14B 81.99B 68.14B 62.01B 117B 7,896B 118B 823B 320B 4,030B 308B 301B 12,954B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.49x
Free-Float
99.99%
Yield 2026 *
0.36%
Yield 2027 * 1.27%
1 day-1.89%
1 week-9.77%
Current month-4.44%
1 month-6.24%
3 months-14.33%
6 months+15.39%
Current year+24.80%
1 week 44.58
Extreme 44.58
49.63
1 month 44.58
Extreme 44.58
51
Current year 32.86
Extreme 32.86
53.98
1 year 25.82
Extreme 25.82
53.98
3 years 18.31
Extreme 18.314
53.98
5 years 18.31
Extreme 18.314
67.97
10 years 18.31
Extreme 18.314
123.8
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.91%-9.77% - - 48.41B
+0.02%-3.52%+36.11%+111.11% 1,019B
-1.21%-6.99%+34.08%+60.96% 610B
+1.12%-0.20%+13.62%+80.24% 470B
-3.30%-6.15%+56.45%+34.69% 344B
+1.28%+1.12%+22.47%+42.36% 336B
+1.01%-2.58%+11.34%+33.29% 266B
+2.21%-2.99%-5.26%+10.18% 241B
-0.01%-3.62%+35.28%+52.02% 218B
-0.08%-4.98%+28.34%+93.61% 179B
Average +0.56%-3.63%+25.82%+57.61% 409.2B
Weighted average by Cap. +0.86%-3.51%+28.63%+68.88%

Financials

2026 *2027 *
Net sales 45.9B 51.45B 42.77B 38.92B 73.29B 4,955B 73.83B 517B 201B 2,529B 193B 189B 8,130B 47.06B 52.75B 43.84B 39.9B 75.14B 5,080B 75.69B 530B 206B 2,593B 198B 194B 8,334B
Net income 2.29B 2.57B 2.14B 1.95B 3.66B 248B 3.69B 25.83B 10.05B 126B 9.65B 9.45B 406B 2.99B 3.35B 2.78B 2.53B 4.77B 322B 4.8B 33.61B 13.07B 164B 12.56B 12.29B 529B
Net Debt 29.96B 33.58B 27.91B 25.4B 47.83B 3,234B 48.18B 337B 131B 1,651B 126B 123B 5,305B 26.84B 30.08B 25B 22.75B 42.85B 2,897B 43.17B 302B 118B 1,479B 113B 110B 4,753B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
02/10/26 €45.80 +0.62% 20,731
01/10/26 €45.52 -5.03% 33,151
30/09/26 €47.93 -1.94% 11,062
29/09/26 €48.88 -3.70% 42,085
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
43.96EUR
Average target price
58.22EUR
Spread / Average Target
+32.44%

Quarterly revenue - Rate of surprise